Tuesday, December 17, 2024
- Advertisement -spot_img

TAG

Medicare

How to choose a Medicare Part D prescription drug plan

Selecting a Part D prescription drug plan is one of the hardest Medicare decisions because there are so many factors to consider: the medications...

UnitedHealthcare CEO kept a low public profile. Then he was shot to death in New York

NEW YORK (AP) — Brian Thompson led one of the biggest health insurers in the U.S. but was unknown to...

Dr. Oz wants to expand private Medicare plans. Here’s how he could do it.

By choosing Dr. Mehmet Oz for a key healthcare post this week, President-elect Donald Trump didn’t just add another TV...

Medicare coverage will change in 2025. Some boomers are already struggling to keep up with their medical bills.

Medicare enrollment is open and insurers are making changes, increasing costs for some.Medicare is a key health insurance source for older Americans, often linked...

How Kamala Harris’s ‘care economy’ would work

Kamala Harris has been releasing her plans for the "care economy" in piecemeal fashion — a strategy very much unlike the other planks of...

Tips for shopping for Medicare Advantage plans

Shopping season for Medicare coverage is about to begin. With it comes the annual onslaught of TV ads and choices to consider.People eligible for...

An appeals court has revived a challenge to President Biden’s Medicare drug price reduction program

NEW ORLEANS (AP) — A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used prescription drugs was...

An appeals court has revived a challenge to President Biden’s Medicare drug price reduction program

NEW ORLEANS (AP) — A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used prescription drugs was...

Challenge to US drug price negotiation program revived by appeals court

By Brendan Pierson(Reuters) - A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law...

Novo says Ozempic ‘very likely’ to be on 2027 Medicare negotiation list, Bloomberg News reports

(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations,...

Latest news

- Advertisement -spot_img